United Orthopedic Corporation (TPEX:4129)

Market Cap	10.27B
Revenue (ttm)	4.88B
Net Income (ttm)	553.05M
Shares Out	96.44M
EPS (ttm)	5.74
PE Ratio	18.57
Forward PE	n/a
Dividend	4.00 (3.76%)
Ex-Dividend Date	n/a

Volume	470,625
Average Volume	655,181
Open	107.50
Previous Close	106.50
Day's Range	106.00 - 107.50
52-Week Range	77.30 - 114.00
Beta	0.47
RSI	62.62
Earnings Date	May 15, 2025

About United Orthopedic

United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fracture, Moore hip prosthesis, and customized artificial hip joints for individual tumor patients; artificial knee joint, such as artificial knee replacement joint, revision knee replacement system, restricted artificial knee joints, and customized artificial knee joints for individual tumor patients; and spine produ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4129

Financial Performance

In 2024, United Orthopedic's revenue was 4.65 billion, an increase of 18.40% compared to the previous year's 3.93 billion. Earnings were 455.96 million, an increase of 20.11%.